Skip to main content

Published locations for Cardiac Risks of Newer Psoriasis Biologics vs. TNF Inhibitors Compared

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Cardiac Risks of Newer Psoriasis Biologics vs. TNF Inhibitors Compared

User login

  • Reset your password
  • /content/cardiac-risks-newer-psoriasis-biologics-vs-tnf-inhibitors-compared
  • /content/cardiac-risks-newer-psoriasis-biologics-vs-tnf-inhibitors-compared
  • /cardiology/article/272094/thrombosis/cardiac-risks-newer-psoriasis-biologics-vs-tnf-inhibitors-compared
  • /rheumatology/article/272094/thrombosis/cardiac-risks-newer-psoriasis-biologics-vs-tnf-inhibitors-compared
  • /internalmedicine/article/272094/thrombosis/cardiac-risks-newer-psoriasis-biologics-vs-tnf-inhibitors-compared
  • /neurology/article/272094/thrombosis/cardiac-risks-newer-psoriasis-biologics-vs-tnf-inhibitors-compared
  • /dermatology/article/272094/thrombosis/cardiac-risks-newer-psoriasis-biologics-vs-tnf-inhibitors-compared
  • /familymedicine/article/272094/thrombosis/cardiac-risks-newer-psoriasis-biologics-vs-tnf-inhibitors-compared